Entrada Therapeutics, Inc.TRDANASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-560.17%
↓ 527% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
-89.39%
Historical baseline
PeriodValueYoY Change
2025-560.17%-2425.0%
202424.09%+9783.3%
2023-0.25%-
20220.00%-
20210.00%-
20200.00%-